F Aileen Bouffard is a notable inventor based in Scotch Plains, NJ (US). She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. With a total of 3 patents to her name, her work has had a meaningful impact on antibiotic development.

Latest Patents

Among her latest patents is a process for the stereocontrolled silyloxyethylation of azetidinones. This stereospecific process is designed for preparing 3-trans-R-trisubstituted silyloxyethyl substituted azetidinones, which serve as intermediates for creating penems and carbapenems. The process involves treating a 3-unsubstituted azetidinone with a strong base and a trisubstituted silylmethyl ketone, leading to the formation of 3-trans-S-[1-trisubstituted silyl-1-hydroxy]ethylazetidinone. This compound is then rearranged through treatment with an alkali metal alkoxide and a proton source. Another significant patent involves substituted azetidinones, which are useful in the preparation of 1-carba-2-penem-3-carboxylic acids. These compounds, along with their pharmaceutically acceptable salt, ester, and amide derivatives, are valuable as antibiotics.

Career Highlights

F Aileen Bouffard is currently employed at Merck & Co., Inc., where she continues to advance her research in pharmaceutical chemistry. Her innovative approaches have led to the development of important compounds that contribute to the field of medicine.

Collaborations

Throughout her career, she has collaborated with esteemed colleagues such as Burton G Christensen and Thomas N Salzmann. These collaborations have further enriched her research and contributed to her success as an inventor.

Conclusion

F Aileen Bouffard's work exemplifies the vital role of innovation in pharmaceutical chemistry. Her patents and contributions to antibiotic development highlight her importance in the field.